Texas Regional Excellence in Cancer (TREC) @Texas A&M University Cancer Prevention Registry and Repository
Summary
This study collects health and genetic information to implement cancer prevention and treatment strategies.
Detailed description
This research will explore how genetics, diet, exercise, and jobs influence the risk of developing cancers that can be treated early. The goal is to find out if this knowledge can help doctors and health insurers improve their methods for preventing cancers that cannot be treated.
Outcome measures
Primary
Frequency and nature of ADRs on the Naranjo Scale Questionnaire
Measure the frequency and nature of adverse drug reactions by obtaining a complete medical history and physical examination and validating the patient's current concomitant medication list during the office visit. Patient medical information would be input into the ActX platform, which functions as a computable EHR medical record analysis, evaluation of polypharmacy status, and monitoring of ADRs using the Naranjo Scale will be conducted for the duration of the study.
Time frame: 5 years
Secondary
Self-reported Health status and any significant changes
Time frame: 5 years
Eligibility criteria
Study locations (1)
Texas A&M Family Care
Bryan, Texas, 77802